We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma.
- Authors
Nagai, Hidenari; Matsui, Teppei; Kanayama, Masahiro; Momiyama, Kouichi; Shizawa, Kazue; Wakui, Noritaka; Shinohara, Mie; Watanabe, Manabu; Iida, Kazunari; Ishii, Koji; Igarashi, Yoshinori; Sumino, Yasukiyo
- Abstract
Purpose: We have previously reported that 24-h intra-arterial combination chemotherapy (IACC) prolongs the survival of patients with advanced hepatocellular carcinoma (aHCC). However, it has also been reported that 5-fluorouracil (5-FU) exacerbates liver damage in patients with liver cirrhosis (LC). The aim of this study was to clarify the hepatotoxicity of IACC in LC patients with aHCC. Methods: Twenty-one adult Japanese patients (20 men and 1 woman) with aHCC and LC underwent IACC between 2004 and 2007 at our hospital. These patients showed multiple partial responses or stable disease, except for five patients who showed no response and three patients with tumors more than 30 mm in diameter. All patients had inoperable disease on the basis of computed tomography (CT) findings. IACC (leucovorin at 12 mg/h, cisplatin at 10 mg/h, and 5-FU at 250 mg/22 h) was delivered via the proper hepatic artery every 5 days for 4 weeks. Results: Twelve patients were in Child-Pugh class A (group A), and nine were in class B (group B). The Child-Pugh score was significantly increased after chemotherapy compared with before chemotherapy in both groups. Serum albumin was significantly decreased after chemotherapy, and the number of patients with ascites also increased after chemotherapy. Serum type IV collagen and N-terminal propeptide of type III procollagen were significantly increased after chemotherapy, although there was no significant change in serum aminotransferases. Conclusions: IACC might cause hepatotoxicity that induces fibrosis without releasing aminotransferases.
- Subjects
HEPATOTOXICOLOGY; DRUG therapy; CIRRHOSIS of the liver; LIVER cancer patients; MEDICAL research; PATIENTS
- Publication
Cancer Chemotherapy & Pharmacology, 2010, Vol 66, Issue 6, p1123
- ISSN
0344-5704
- Publication type
Academic Journal
- DOI
10.1007/s00280-010-1270-8